FDA Approved: BUPRENORPHINE — Supplemental Application (Actavis Pharma, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for buprenorphine from Actavis Pharma, Inc. under the ANDA, indicating changes to labeling or indications.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Opioid Use Disorder
• Pain

Drugs mentioned

• buprenorphine (buprenorphine)

Snippet

SUPPL AP for BUPRENORPHINE (BUPRENORPHINE)